Td Asset Management Inc Innoviva, Inc. Transaction History

Td Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$14.32 - $19.88 $410,984 - $570,556	-28,700 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$15.39 - $20.25 $196,992 - $259,200	12,800 Added 80.5%	28,700 $555,000
Q4 2021 Feb 10, 2022	SELL	$15.91 - $18.72 $832,093 - $979,055	-52,300 Reduced 76.69%	15,900 $274,000
Q3 2021 Nov 09, 2021	SELL	$13.06 - $17.24 $397,024 - $524,095	-30,400 Reduced 30.83%	68,200 $1.14 Million
Q1 2021 May 14, 2021	BUY	$11.06 - $12.87 $325,164 - $378,378	29,400 Added 42.49%	98,600 $1.18 Million
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $460,902 - $616,512	-49,400 Reduced 41.65%	69,200 $857,000
Q3 2020 Nov 10, 2020	BUY	$10.33 - $14.49 $454,520 - $637,560	44,000 Added 58.98%	118,600 $1.24 Million
Q2 2020 Aug 13, 2020	BUY	$11.49 - $15.26 $857,154 - $1.14 Million	74,600 New	74,600 $1.04 Million
Q1 2019 May 08, 2019	SELL	$13.69 - $20.06 $470,936 - $690,064	-34,400 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$13.96 - $18.26 $50,256 - $65,736	3,600 Added 11.69%	34,400 $600,000
Q3 2018 Nov 01, 2018	SELL	$13.63 - $15.7 $1.61 Million - $1.85 Million	-118,000 Reduced 79.3%	30,800 $469,000
Q2 2018 Jul 31, 2018	BUY	$13.44 - $17.59 $2 Million - $2.62 Million	148,800 New	148,800 $2.05 Million

226

78.7M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.3B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.